Thermo Fisher Scientific Inc

TMO
Passed

Company Overview

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Country
US
Market Cap
$203.03B
Last Fiscal Year
2023
Final Shariah Status
Passed
Compliance Analysis Overview

Shariah Compliance Benchmarks:

  • Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
  • Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
Business Compliance
0.60% passed
5% Threshold
0.6%
Liabilities Compliance
17.20% passed
33% Threshold
17.2%
Final Shariah Status
Passed

This stock meets all Shariah compliance criteria according to AAOIFI standards.

Stock Information
Name Thermo Fisher Scientific Inc
Ticker TMO
Main Business Diagnostics & Research
Type Common Stock
Industry Diagnostics & Research
Country US
Market Cap $203.03 B

Shariah Analysis Breakdown

Business compliance Breakdown
Revenue Segment Value ($M) Non-Compliant ($M) Reason
Laboratory Products and Biopharma Services $22,510.0 $0.0 -
Life Sciences Solutions $13,530.0 $0.0 -
Analytical Instruments $6,620.0 $0.0 -
Specialty Diagnostics $4,760.0 $0.0 -
Eliminations $-2,520.0 $0.0 -
Interest income $272.0 $272.0 -
Total $45,172.0 $272.0 0.60% (passed)
Liabilities Compliance Breakdown
Liability Item Value ($M) % of Market Cap
current debt and capital lease obligation $3,610,000,000.0 1.78%
long term debt and capital lease obligation $31,310,000,000.0 15.42%
Total Interest-Bearing Debt $34,920,000,000.0 17.20%
Market Capitalization $203,027,175,000.0 100.00%
Compliance Status Threshold: 33% passed